Abstract

Drug Compatibility and Stability in Dextrose vs Saline

Author(s): Newton David W

Issue: May/Jun 2011 - Volume 15, Number 3

Page(s): 190-192

Download in electronic PDF format for $75

Abstract

This article was prompted by a pharmacy student’s question about the differences in drug compatibility and stability between dextrose and saline injections. The article briefly compares

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
May/Jun 2011 Pg. 190-192	Drug Compatibility and Stability in Dextrose vs Saline Author(s): Newton David W
Mar/Apr 1997 Pg. 132-134	Stability of Aminocaproic Acid Injection Admixtures in 5% Dextrose Injection and 0.9% Sodium Chloride Injection Author(s): Zhang Yan-ping, Trissel Lawrence A
Jul/Aug 2001 Pg. 323-324	Compatibility and Stability of Potassium Chloride and Magnesium Sulfate in 0.9% Sodium Chloride Injection and 5% Dextrose Injection Solutions Author(s): Quay Irene, Tan Edward
Jan/Feb 2000 Pg. 66-68	Stability of Alatrofloxacin Mesylate in 5% Dextrose Injection and 0.45% Sodium-Chloride Injection Author(s): Gupta Vishnu D, Bailey RE
May/Jun 2013 Pg. 254-261	Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline Author(s): Klemmer Anja, Krämer Irene, Kamin Wolfgang
Sep/Oct 2007 Pg. 426-432	Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion Author(s): Desai Narendra R, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A
Nov/Dec 1997 Pg. 435-436	Stability of Cefepime Hydrochloride Dextrose in 5% Dextrose Injection and 0.9% Sodium Chloride Injection Author(s): Gupta Vishnu D, Maswoswe J, Bailey RE
May/Jun 2020 Pg. 242-245	Physicochemical Stability and Compatibility of Revefenacin (LAMA) and Formoterol Fumarate (LABA) Inhalation Solution Admixture Author(s): Ngim Kenley, Patel Jalpa
Nov/Dec 2022 Pg. 522-526	Intravenous Physical Compatibility of Heparin Sodium and Furosemide Author(s): Maktabi Briana, Howard Mitchell S, Baki Gabriella, Churchwell Mariann D
May/Jun 1997 Pg. 208-209	Stability of Cefmetazole Sodium in 5% dextrose Injection and 0.9% Sodium Chloride Injection Author(s): Gupta Vishnu D, Maswoswe J, Bailey RE
Jan/Feb 2021 Pg. 52-61	Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration Author(s): Lu Juan, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
Sep/Oct 2017 Pg. 436-439	Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags Author(s): Marquis Kathleen, Hohlfelder Benjamin, Szumita Paul M
May/Jun 1997 Pg. 206-207	Stability of Ketorolac Tromethamine in 5% Dextrose Injection and 0.9% Sodium Chloride Injections Author(s): Gupta Vishnu D, Maswoswe J, Bailey RE
Mar/Apr 1998 Pg. 168-169	Stability of Milrinone Lactate 200 mcg/mL in 5% Dextrose Injection and 0.9% Sodium Chloride Injection Author(s): Wong Frances, Gill Mark A
Nov/Dec 2007 Pg. 520-524	Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
May/Jun 2004 Pg. 228-230	Physical and Chemical Stability of Trepostinil Sodium Injection Packaged in Plastic Syringe Pump Reservoirs. Author(s): Xu Quanyun A, Trissel Lawrence A, Pham Lien
Mar/Apr 2004 Pg. 153-155	Chemical Stability of Phenylephrine HCl After Reconstitution in 0.9% Sodium Chloride Injection for Infusion Author(s): Gupta Vishnu D
May/Jun 2006 Pg. 230-233	Compatibility of Micafungin Injection with Other Drugs During Simulated Y-Site Co-administration Author(s): Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
May/Jun 2008 Pg. 276-278	Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration Author(s): Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A
Jul/Aug 2002 Pg. 311-315	Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs Author(s): Trissel Lawrence A, Saenz Christopher